Moderna’s CEO Stéphane Bancel spoke at the Boston College Chief Executives Club on April 5. While COVID-19 vaccine production was a big talking point for the leader of Moderna, he also touched on how mRNA technology can usher us into a longer life span, saying that he tells all of his friends to “not die” in the next ten years.
Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support
Alzheimer’s disease, Clinical Trials, COVID-19 booster shots, Dementia, Herpes Simplex Virus, Medical Journals, Molecules, Multiple Sclerosis, Myelin, Nature Communications, Neurogenerative diseases, Peptides, Proteins, R&D, Rice University, The Lancet, University of Houston, University of Illinois at ChicagoResearchers at the University of Illinois at Chicago published what they are calling a “first of its kind study” that found a possible direct link between neurodegenerative diseases and the herpesvirus.
Research Roundup: Major Breakthrough in HIV Research and More
Australia, China, Coronavirus Disease 2019 (COVID-19), Drug Cocktails, Genes, Genetic Markers, Genomes, Germany, Herpes Simplex Virus, HIV, Immune Cells, Medical Journals, Mount Sinai, Neurodegenerative Diseases, New England Journal of Medicine, Nucleotides, R&D, RNA, San Francisco (UCSF), Science, Scientific studies, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Netherlands, Thrombosis Research, University of Alabama at Birmingham (UAB), University of Maryland Baltimore County, Walter and Eliza Hall InstituteA review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
International Team Develops Promising Broad-Spectrum Antiviral Compound
Antivirals, Biotech, Cyclodextrins, Hepatitis, Herpes Simplex Virus, HIV, HIV Virus, Molecules, Mutations, R&D, Respiratory Syncytial Virus (RSV) Infection, Science Advances, University of Geneva (UNIGE), University of Manchester, Viruses, Zika VirusAn international team of researchers led by the University of Manchester developed a new antiviral using natural glucose derivatives called cyclodextrins – a type of sugar – which shows promise in treating a broad range of viruses including herpes simplex, respiratory syncytial virus, hepatitis C, HIV and Zika virus.
Three Small CRISPR Biotechs That Could Cure 10,000 Diseases
Blood Diseases, Cancer, Collaborations, CRISPR/Cas9, Diseases, DNA, Eye Diseases, FDA, Gene Editing, Genetic Disorders, Genomics, Hematopoietic Stem Cells, Herpes Simplex Virus, Hunter Syndrome, Immune Cells, Inflammatory Disorders, J.P. Morgan Healthcare Conference, Liver Disease, Lung Disease, Muscle Disease, R&D, Sickle Cell Disease, Thalassemia, Transthyretin (TTR) Amyloidosis, Viral Infections, World Health OrganizationInvestor’s Business Daily looked at three small biotech companies that appear to be leading the CRISPR race.
Emails Reveal Theranos CEO Sought Marine General’s Help in Skirting Federal Inquiry
Blood Tests, Blood Tests, Business, Department of Defense, Drugstore Chains, FDA/Regulatory, Health, Herpes, Herpes Simplex Virus, Medical Devices, Pharmacies, Pharmacy Benefit Manager, Pharmacy Benefit Managers, Pharmacy Benefot ManagersPALO Alto, Calif. – Blood-testing company Theranos continues to face scrutiny following a Washington Post report that alleges the company was attempting to skirt federal law by asking a Department of Defense official to intervene in an inquiry by the U.S. Food and Drug Administration (FDA). In 2012, the Department of Defense raised concerns about […]
Two-thirds of the world’s population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease. More than 3.7 billion people under the age of 50 suffer from the herpes simplex virus type 1 […]
FDA approves Amgen’s injected immunotherapy for melanoma
Analysts, Approvals, Biologics License Application (BLA), Biotech, Biotechnology, Clinical Trials, FDA, FDA/Regulatory, Forecasts, Health, Herpes, Herpes Simplex Virus, Immune System, Immune Systems, Immunotherapies, Immunotherapy, Melanoma, Melanoma Lesions, Pricing, R&D, Shares, Shares, Studies, Viral Therapy, Wall Street, Warning LabelingU.S. health regulators on Tuesday approved Amgen Inc’s novel cancer immunotherapy for injection into melanoma lesions and lymph nodes of patients with the deadliest form of skin cancer that returns after initial surgery. The drug, to be sold under the brand name Imlygic, is an engineered version of a herpes virus that kills cancer cells […]
Amgen wins EU green light for first virus-based cancer drug
Approvals, Approvals, BRAF V600 Inhibitors, BRAF V600 inhibitors, Cancer Cells, EMA, FDA, FDA/Regulatory, Health, Herpes, Herpes Simplex Virus, Immune Response, Immunotherapies, Immunotherapy, M&A, M&A, MEK Inhibitors, MEK Inhibitors, Melanoma, New Drug ApprovalsA first-in-class drug from Amgen based on a tumor-killing virus was given a green light by European regulators on Friday, paving the way for its approval within a couple of months. The decision is a further milestone for a technology that has long fascinated scientists but has previously proved difficult to harness. The European […]